Share This

Public company info - Charmacy Pharmaceutical Co. Ltd. - H Shares , 02289.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Charmacy Pharmaceutical Co. Ltd. - H Shares, 02289.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12
Net Cash Flow from Operating Activities 80,067 17,878 158,007 43,212 89,871 3,557 -82,344 211,644 -6,511 51,426 66,914
Net Cash Flow from Return on Investments & Servicing of Finance -28,440 -52,494 -56,512 -61,575 -48,360 -51,084 -34,404 -65,449 -18,099 -16,562 -16,554
　Interest Received 0 0 0 0 0 0 3,342 4,650 4,733 3,988 3,106
　Interest Paid 0 0 0 0 0 0 -16,607 -24,099 -22,832 -20,550 -19,660
　Dividend Received 0 0 0 0 0 0 0 0 0 0 0
　Dividend Paid -28,440 -52,494 -56,512 -61,575 -48,360 -51,084 -21,139 -46,000 0 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -36,017 -37,421 -26,931 -39,193 -40,720 -36,517 -18,540 -17,974 -8,315 -6,322 -5,214
Net Cash Flow from Investing Activities 71,762 -24,402 -54,780 -73,744 -97,569 -123,362 -34,177 -172,520 36,170 -65,693 -107,324
　Additions to Fixed Assets -8,589 -25,040 -51,982 -73,903 -97,726 -125,625 -21,958 -30,311 -4,447 -5,104 -41,833
　Disposal of Fixed Assets 80,351 638 58 160 157 177 158 30 681 220 5
　Increase in Investments 0 0 -2,856 0 0 0 0 0 0 0 0
　Decrease in Investments 0 0 0 0 0 0 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0
　Others 0 0 0 -1 0 2,086 -12,377 -142,239 39,936 -60,809 -65,496
Net Cash Flow before Financing Activities 87,373 -96,439 19,785 -131,299 -96,778 -207,407 -169,465 -44,299 3,245 -37,151 -62,178
Net Cash Flow from Financing Activities -162,772 126,895 53,836 115,701 77,520 164,702 133,406 177,632 2,290 41,566 61,514
　New Loans 825,887 957,971 950,409 784,884 692,100 750,400 457,362 312,650 264,850 271,270 265,314
　Loans Repayment -1,070,916 -820,495 -884,997 -574,926 -671,300 -507,482 -326,650 -323,350 -263,060 -230,204 -204,300
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 188,332 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 0 0 0 0 0 0
　Others 82,257 -10,581 -11,576 -94,257 56,720 -78,216 2,694 0 500 500 500
Increase(Decrease) in Cash & Cash Equivalents -75,399 30,455 73,621 -15,598 -19,258 -42,704 -36,059 133,333 5,535 4,415 -664
Cash & Cash Equivalents at Beginning of Year 144,227 113,771 40,149 55,739 75,097 119,569 155,629 22,296 16,761 12,346 13,010
Net Cash Flow due to Change in Exchange Rate/Others 33 0 1 9 -101 -1,768 0 0 0 0 0
Cash & Cash Equivalents at End of Year 68,861 144,227 113,771 40,149 55,739 75,097 119,570 155,629 22,296 16,761 12,346
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.